Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Operation
Despite the efficacy and potential therapeutic benefits that poly(lactic-co-glycolic acid) (PLGA) nanomedicine formulations can offer, challenges related to large-scale processing hamper their clinical and commercial development. Major hurdles for the launch of a polymeric nanocarrier product on the...
Saved in:
Main Authors: | Maria Camilla Operti (Author), Alexander Bernhardt (Author), Vladimir Sincari (Author), Eliezer Jager (Author), Silko Grimm (Author), Andrea Engel (Author), Martin Hruby (Author), Carl Gustav Figdor (Author), Oya Tagit (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing
by: Maria Camilla Operti, et al.
Published: (2022) -
Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles
by: Maria Camilla Operti, et al.
Published: (2019) -
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
by: Antonietta Vilella, et al.
Published: (2015) -
PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
by: Hashem O. Alsaab, et al.
Published: (2022) -
Downstream
by: Siwertz, Sigfrid, 1882-1970; Classen, E. (Ernest), 1881- [Translator]